Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Bronchoscopy & lung nodule · Rhode Island | Bronchoscopy & lung nodule · Pennsylvania | |
|---|---|---|
| Surgeons, 2024 | 4 | 75 |
| Medicare fee-for-service cases | 147 | 5,343 |
| Growth since 2019 (Medicare FFS) | +4.9%/yr | +1.2%/yr |
| Forecast cases (Medicare FFS) | 310 in 2030 | 7,380 in 2030 |
| Forecast growth | +13%/yr to 2030 | +5.5%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 1.6 | 4.0 |
| Medicare Advantage share | 66% | 58% |
| Out of hospital | 0% | 0% (+0 pts since 2019) |
| Cases per surgeon | 37 | 71 |
| Top 10 surgeons' share | 100% | 41% |
| Surgeons growing | 0 | 14 |
| New since the base year | 0 | 21 |
| Likely to stop billing it | 1 by 2026 | 15 by 2026 |
| Forecast miss, 1 year (procedure) | 6% | 6% |
| Company payments per surgeon | $664 | $4,953 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.